Salt Wasting and Deafness Resulting from Mutations in Two Chloride Channels

New England Journal of Medicine

Volumn 350, Issue 13, 2004, Pages 1314-1319

  Schlingmann, Karl P ^a   Konrad, Martin ^a   Jeck, Nikola ^a   Waldegger, Petra ^a   Reinalter, Stephan C ^a   Holder, Martin ^b   Seyberth, Hannsjörg W ^a   Waldegger, Siegfried ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b Olgahospital Stuttgart ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BARTTIN; CHLORIDE CHANNEL; ION CHANNEL; PROTEIN; SODIUM POTASSIUM CHLORIDE COTRANSPORTER; UNCLASSIFIED DRUG;

ARTICLE; BARTTER SYNDROME; CASE REPORT; CHROMOSOME 1P; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; GENE MUTATION; GENETIC ANALYSIS; GITELMAN SYNDROME; HEARING IMPAIRMENT; HUMAN; HYDRAMNIOS; HYPOKALEMIA; INNER EAR; ION TRANSPORT; KIDNEY DISEASE; MALE; METABOLIC ALKALOSIS; NEPHRON; NEWBORN; NUCLEOTIDE SEQUENCE; PERCEPTION DEAFNESS; PHENOTYPE; PRIORITY JOURNAL; SALT LOSING NEPHRITIS;

ANIMALS; ANION TRANSPORT PROTEINS; BARTTER SYNDROME; CHLORIDE CHANNELS; CHROMOSOMES, HUMAN, PAIR 1; DEAFNESS; DNA MUTATIONAL ANALYSIS; GENE DELETION; HEARING LOSS, SENSORINEURAL; HUMANS; HYPOKALEMIA; INFANT; KIDNEY DISEASES; MALE; MEMBRANE PROTEINS; MUTATION, MISSENSE; OOCYTES; POINT MUTATION; XENOPUS LAEVIS;

EID: 1642366722     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa032843     Document Type: Article

References (21)

1. Seyberth HW, Soergel M, Köckerling A. Hypokalaemic tubular disorders: the hyperprostaglandin E syndrome and the Gitelman-Bartter syndrome. In: Davison AM, Cameron JS, Grünfeld J-P, Kerr DNS, Ritz E, Winearls CG, eds. Oxford textbook of clinical nephrology. 2nd ed. Vol. 2. Oxford, England: Oxford University Press, 1998:1085-93.
2. Bartter FC, Pronove P, Gill JR Jr, MacCardle RC. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis: a new syndrome. Am J Med 1962;33:811-28.
3. Gitelman HJ, Graham JB, Welt LG. A new familial disorder characterized by hypokalemia and hypomagnesemia. Trans Assoc Am Physicians 1966;79:221-35.
4. Seyberth HW, Rascher W, Schweer H, Kuhl PG, Mehls O, Scharer K. Congenital hypokalemia with hypercalciuria in preterm infants: a hyperprostaglandinuric tubular syndrome different from Bartter syndrome. J Pediatr 1985;107:694-701.
5. Simon DB, Karet FE, Hamdan JM, DiPietro A, Sanjad SA, Lifton RP. Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat Genet 1996;13:183-8.
6. + channel, ROMK. Nat Genet 1996;14:152-6.
7. Simon DB, Bindra RS, Mansfield TA, et al. Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. Nat Genet 1997;17:171-8.
8. Simon DB, Nelson-Williams C, Bia MJ, et al. Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet 1996;12:24-30.
9. Landau D, Shalev H, Ohaly M, Carmi R. Infantile variant of Bartter syndrome and sensorineural deafness: a new autosomal recessive disorder. Am J Med Genet 1995;59:454-9.
10. Birkenhager R, Otto E, Schurmann MJ, et al. Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure. Nat Genet 2001;29:310-4.
11. + secretion. Nature 2001;414:558-61.
12. Waldegger S, Jeck N, Barth P, et al. Barttin increases surface expression and changes current properties of ClC-K channels. Pflugers Arch 2002;444:411-8.
13. Haas NA, Nossal R, Schneider CH, et al. Successful management of an extreme example of neonatal hyperprostaglandin-E syndrome (Bartter's syndrome) with the new cyclooxygenase-2 inhibitor rofecoxib. Pediatr Crit Care Med 2003;4:249-51.
14. Konrad M, Vollmer M, Lemmink HH, et al. Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome. J Am Soc Nephrol 2000;11:1449-59.
15. Van Naarden K, Decoufle P. Relative and attributable risks for moderate to profound bilateral sensorineural hearing impairment associated with lower birth weight in children 3 to 10 years old. Pediatrics 1999;104:905-10.
16. Peters M, Jeck N, Reinalter S, et al. Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies. Am J Med 2002;112:183-90.
17. Jeck N, Reinalter SC, Henne T, et al. Hypokalemic salt-losing tubulopathy with chronic renal failure and sensorineural deafness. Pediatrics 2001;108:e5. (Accessed February 19, 2004, at http://pediatrics.aappublications.org/cgi/content/full/108/1/e5.)
18. Uchida S, Sasaki S, Nitta K, et al. Localization and functional characterization of rat kidney-specific chloride channel, ClC-K1. J Clin Invest 1995;95:104-13.
19. Yoshikawa M, Uchida S, Yamauchi A, et al. Localization of rat CLC-K2 chloride channel mRNA in the kidney. Am J Physiol 1999;276:F552-F558.
20. Matsumura Y, Uchida S, Kondo Y, et al. Overtnephrogenic diabetes insipidus in mice lacking the CLC-K1 chloride channel. Nat Genet 1999;21:95-8.
21. Akizuki N, Uchida S, Sasaki S, Marumo F. Impaired solute accumulation in inner medulla of Clcnk1-/- mice kidney. Am J Physiol Renal Physiol 2001;280:F79-F87.